Sahaj Regenerative Cell Therapeutics Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.00 M
as on 07-06-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.82 Cr
as on 07-06-2024
- Revenue -91.62%
(FY 2021)
- Profit -38.79%
(FY 2021)
- Ebitda -45.88%
(FY 2021)
- Total Assets 2.64%
(FY 2021)
About Sahaj Regenerative Cell Therapeutics Llp
- CIN/LLPIN/FCRN
AAD-9198
- Incorporation Date
12 May 2015
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Gwalior
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sahaj Regenerative Cell Therapeutics Llp?
Designated Partners(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priti Jain  | Designated Partner | 12-May-2015 | Current |
| Vinod Jain | Designated Partner | 28-May-2015 | Current |
| Sulochana Bohara | Designated Partner | 12-May-2015 | Current |
Financial Performance of Sahaj Regenerative Cell Therapeutics Llp.
Sahaj Regenerative Cell Therapeutics Llp, for the financial year ended 2021, experienced significant reduction in revenue, with a 91.62% decrease. The company also saw a substantial fall in profitability, with a 38.79% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sahaj Regenerative Cell Therapeutics Llp?
Unlock access to Sahaj Regenerative Cell Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sahaj Hospitals Private LimitedActive 16 years 4 monthsPriti Jain and Sulochana Bohara are mutual person
- Sahaj Innovative Cell Therapy Private LimitedActive 9 years 7 months
Priti Jain and Sulochana Bohara are mutual person
- Hope Diagnostic And Fertility Centre Private LimitedActive 22 years 1 month
Priti Jain and Vinod Jain are mutual person
- Sahaj Regenerative Cell Therapeutics Private LimitedActive 11 months 17 days
Priti Jain, Vinod Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Bank Limited Creation Date: 24 Jul 2017 | ₹2.82 Cr | Open |
How Many Employees Work at Sahaj Regenerative Cell Therapeutics Llp?
Unlock and access historical data on people associated with Sahaj Regenerative Cell Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahaj Regenerative Cell Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahaj Regenerative Cell Therapeutics Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
